Adam Miles

Adam Miles is a veteran product manager working to make life easier for every user in experimental biophysics, humans, systems and machines alike. He is co-founder and co-CEO of Instromeda, building their first product, the SPRneo, an agent-native surface plasmon resonance platform. He began at Wasatch Microfluidics/Carterra in 2007 as a founding engineer, embedded in the Myszka laboratory working on SPRi systems, microarraying technologies and their direct integration, the innovations that were boxed up in the LSA platform. He collaborated with Pfizer, where he drove high-throughput epitope binning and kinetic characterization to 384-ligand array capacity and analysis techniques. He was a product leader at Bruker and Nicoya, where he led a number of successful product entries in biophysics. At Exscientia he co-led a skunkworks team working on the hard problems in automated biophysics, before spinning out one of their projects as Instromeda. Probably swimming. Or thinking about it.